Knowledge Hub

OncoSec Medical Inc. (ONCS) - Product Pipeline Analysis

Press release   •   Jul 21, 2016 07:18 EDT

p { margin-bottom: 0.25cm; line-height: 120%; }a:link { }

OncoSec Medical Inc. (OncoSec) is a biotechnology company that offers services to stimulate bodys immune system and attack cancer. The company offers treatment for diseases such as metastatic melanoma, head and neck cancer, and triple negative breast cancer. It provides platform such as ImmunoPulse that is designed to enhance local delivery and uptake DNA-based therapeutics into tumors. The companys technology includes electroporation that involves electrical pulse to increase the permeability of cell membrane and permits the DNA to enter the cells. Its immunotherapy platform, ImmunoPulse, a naturally occurring protein with immune-stimulating functions focuses on the delivery of DNA-based interleukin-12 (IL-12). OncoSec is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company OncoSec Medical Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Download Sample Copy of This Report at: